As pharmaceutical companies face increased national scrutiny over transparency and corporate oversight, universities partnered with the industry are paying closer attention to how research is funded and commercialized. The University of Michigan has expanded its work with pharmaceutical companies in recent years, even as it currently pursues legal action against AstraZeneca for allegedly commercializing University-developed research without a finalized agreement.

Nationally, political figures, consumer advocate and watchdog groups have raised concerns about drug pricing, licensing transparency and ethical practices. High-profile critics like Robert F. Kennedy Jr., U.S. Secretary of Health and Human Services, have amplified public pressure on companies that dominate the U.S

See Full Page